GSA CAPITAL PARTNERS LLP - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 117 filers reported holding THERAVANCE INC in Q4 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of THERAVANCE INC
ValueSharesWeighting
Q2 2015$453,000
-39.2%
25,087
-47.1%
0.02%
-43.3%
Q1 2015$745,000
+78.2%
47,417
+60.6%
0.03%
+3.4%
Q4 2014$418,000
-65.7%
29,517
-58.6%
0.03%
-54.7%
Q3 2014$1,217,000
+156.2%
71,237
+364.1%
0.06%
+88.2%
Q1 2014$475,00015,3510.03%
Other shareholders
THERAVANCE INC shareholders Q4 2014
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders